Cibus Inc. (CBUS) - Forward Price-to-Revenue Multiple

Graphic logo of Cibus, Inc (CBUS)

The transition to commercial scaling via trait licensing to seed giants is driving growth, as confirmed by the projected market cap-to-revenue ratio, where the value 19.30 captures this metric. Cibus, Inc. (CBUS) leverages its leadership in non-GMO editing for the global agricultural sector and the top management's expertise in developing climate-resilient crops with enhanced traits as its foundation.

cibus.com - CBUS Market Cap to Future Revenue Ratio (period 02/21/2024 - 11/13/2026)

Comprehensive metric breakdowns and analytics for Cibus, Inc (CBUS)

- stock price and consensus target price:
Stock Quotes Cibus|CBUS - Fair Value Consensus
- market capitalization indicators:
Market Valuation Cibus, Inc|CBUS - Aggregate Business Value
- business book valuation details:
Book Value per Share Cibus|CBUS - Total Stockholders' Equity|Market Capitalization to Book Value Ratio cibus.com|CBUS - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Cibus, Inc.|CBUS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Cibus, Inc.|CBUS - Company Aggregate Debt|Debt to Book Capitalization Ratio Cibus, Inc|CBUS - Long-Term Debt|Company Short-Term Debt Cibus|Quick Liquidity cibus.com
- financial results and valuation multiples details:
CBUS - Company Net Income|Projected Future Earnings Cibus, Inc.|CBUS - Market Cap to Net Income Ratio|Projected Price to Earnings Cibus Global|CBUS - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Cibus, Inc|CBUS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Cibus|CBUS - Net earnings per share for the last four quarters|Quarterly EPS earnings growth cibus.com|CBUS - Earnings per share growth in current year|Expected earnings per share growth for next year Cibus, Inc.
- revenue and sales details:
CBUS - Revenue and Sales Volume|Company Projected Revenue Cibus|CBUS - Price-to-Revenue Coefficient|Forward Price-to-Revenue Multiple Cibus, Inc
Fundamental company valuation:CBUS (Cibus)
Product sample of Cibus, Inc.

Cibus, Inc. (CBUS) is commercializing innovative plant genome editing to enhance crop resilience, which defines its current stage of active growth. An analysis of the forward price-to-sales ratio with a value of 19.30 allows for a comparison of market capitalization against expected revenues, helping investors distinguish fundamental asset undervaluation from systemic business decline and identify the trend reversal point in a timely manner.

Competitor analysis

IDEXX - Forward Price-to-Revenue Multiple|Forward Price to Sales TRMB|NEOG: Forward Price-to-Revenue Multiple|Zhengye Corp - Price to Expected Revenue Ratio|YMT: Forward P/S Multiple|Market Cap to Future Revenue Ratio biocerescrops.com (BIOX)|GRWG (GrowGeneration Corp) - Forward P/S Multiple|Forward Price-to-Revenue Multiple RYTHM (RYM)|Forward P/S Multiple WFCF|UAVS (ageagle.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio The GrowHub Ltd TGHL|IPW: Market Cap to Projected Revenue|HYFM - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio CEA Industries Inc|urban-gro.com (UGRO) - Price-to-Projected Revenue Ratio|NITO (N2OFF) - Price-to-Projected Revenue Ratio|Price-to-Projected Revenue Ratio Arcadia Biosciences|Market Cap to Future Revenue Ratio agriforcegs.com AGRI|Forward P/S Multiple AGFY|Benson Hill Inc. (BHIL) - Projected Price to Revenue|Surna - Forward Price-to-Revenue Multiple|Tingo Corp (TIO) - Market Cap to Future Revenue Ratio